Interleukin-10

DB12880InvestigationalProtein Based Therapies

Interleukin-10 has been used in trials studying the prevention and treatment of Vasculitis, Pancreatitis, Bile Duct Diseases, Pancreatic Diseases, and Gallbladder Diseases, among others.

Mechanism: Pharmacologically active on Interleukin-10 receptor subunit beta and Interleukin-10 receptor subunit alpha
Curator reviewed
Also known as: IL-10 · IL-10 (nonglycosylated)

Resolves to

Compound

UNII9SC4O216V9

Clinical / RWD

RxNorm1311299

Targets

Q08334IL10RBQ13651IL10RA

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Interleukin-10, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account